Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.04 USD | +0.60% | +3.28% | +19.43% |
05-08 | Transcript : Vanda Pharmaceuticals Inc., Q1 2024 Earnings Call, May 08, 2024 | |
05-08 | Earnings Flash (VNDA) VANDA PHARMACEUTICALS Reports Q1 Revenue $47.5M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.43% | 293M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- VNDA Stock
- News Vanda Pharmaceuticals Inc.
- Jefferies Downgrades Vanda Pharmaceuticals to Hold From Buy, Adjusts Price Target to $12 From $24